Global Pet Disease Drugs Supply, Demand and Key Producers, 2023-2029

Global Pet Disease Drugs Supply, Demand and Key Producers, 2023-2029

Page: 131

Published Date: 19 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Pet Disease Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

These drugs are used to quiet anxious pets or help in reducing anxiety associated with various behavioral issues in pets.

This report studies the global Pet Disease Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pet Disease Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pet Disease Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pet Disease Drugs total production and demand, 2018-2029, (K Units)
Global Pet Disease Drugs total production value, 2018-2029, (USD Million)
Global Pet Disease Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pet Disease Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Pet Disease Drugs domestic production, consumption, key domestic manufacturers and share
Global Pet Disease Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Pet Disease Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pet Disease Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Pet Disease Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc., Ceva, Vetoquinol S.A., Zoetis, Virbac, Bimeda, Calier, Boehringer Ingelheim and Elanco Animal Health, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pet Disease Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pet Disease Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Pet Disease Drugs Market, Segmentation by Type
Parasiticides
Anti-infectives
Anti-inflammatory
Analgesics
Others

Global Pet Disease Drugs Market, Segmentation by Application
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other

Companies Profiled:
Merck & Co., Inc.
Ceva
Vetoquinol S.A.
Zoetis
Virbac
Bimeda
Calier
Boehringer Ingelheim
Elanco Animal Health
Dechra Pharmaceuticals
Norbrook Laboratories
Chanelle Pharma
K-Laser USA
Assisi Animal Health
Multi Radiance Medical
Avazzia
SOUND Technologies
IRM Enterprises
Ashish Life Science
Century Pharmaceuticals
VETINDIA Pharmaceuticals
Ourofino Animal Health
SeQuent Scientific
LABINDIA Healthcare
Morvel Laboratories
Richter Pharma
Zuche Pharmaceuticals
Fidelis Animal Health

Key Questions Answered
1. How big is the global Pet Disease Drugs market?
2. What is the demand of the global Pet Disease Drugs market?
3. What is the year over year growth of the global Pet Disease Drugs market?
4. What is the production and production value of the global Pet Disease Drugs market?
5. Who are the key producers in the global Pet Disease Drugs market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Pet Disease Drugs Introduction
1.2 World Pet Disease Drugs Supply & Forecast
1.2.1 World Pet Disease Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Pet Disease Drugs Production (2018-2029)
1.2.3 World Pet Disease Drugs Pricing Trends (2018-2029)
1.3 World Pet Disease Drugs Production by Region (Based on Production Site)
1.3.1 World Pet Disease Drugs Production Value by Region (2018-2029)
1.3.2 World Pet Disease Drugs Production by Region (2018-2029)
1.3.3 World Pet Disease Drugs Average Price by Region (2018-2029)
1.3.4 North America Pet Disease Drugs Production (2018-2029)
1.3.5 Europe Pet Disease Drugs Production (2018-2029)
1.3.6 China Pet Disease Drugs Production (2018-2029)
1.3.7 Japan Pet Disease Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pet Disease Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pet Disease Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Pet Disease Drugs Demand (2018-2029)
2.2 World Pet Disease Drugs Consumption by Region
2.2.1 World Pet Disease Drugs Consumption by Region (2018-2023)
2.2.2 World Pet Disease Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Pet Disease Drugs Consumption (2018-2029)
2.4 China Pet Disease Drugs Consumption (2018-2029)
2.5 Europe Pet Disease Drugs Consumption (2018-2029)
2.6 Japan Pet Disease Drugs Consumption (2018-2029)
2.7 South Korea Pet Disease Drugs Consumption (2018-2029)
2.8 ASEAN Pet Disease Drugs Consumption (2018-2029)
2.9 India Pet Disease Drugs Consumption (2018-2029)

3 World Pet Disease Drugs Manufacturers Competitive Analysis
3.1 World Pet Disease Drugs Production Value by Manufacturer (2018-2023)
3.2 World Pet Disease Drugs Production by Manufacturer (2018-2023)
3.3 World Pet Disease Drugs Average Price by Manufacturer (2018-2023)
3.4 Pet Disease Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pet Disease Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pet Disease Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Pet Disease Drugs in 2022
3.6 Pet Disease Drugs Market: Overall Company Footprint Analysis
3.6.1 Pet Disease Drugs Market: Region Footprint
3.6.2 Pet Disease Drugs Market: Company Product Type Footprint
3.6.3 Pet Disease Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Pet Disease Drugs Production Value Comparison
4.1.1 United States VS China: Pet Disease Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Pet Disease Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Pet Disease Drugs Production Comparison
4.2.1 United States VS China: Pet Disease Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pet Disease Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Pet Disease Drugs Consumption Comparison
4.3.1 United States VS China: Pet Disease Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Pet Disease Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Pet Disease Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pet Disease Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Pet Disease Drugs Production (2018-2023)
4.5 China Based Pet Disease Drugs Manufacturers and Market Share
4.5.1 China Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pet Disease Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Pet Disease Drugs Production (2018-2023)
4.6 Rest of World Based Pet Disease Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pet Disease Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Pet Disease Drugs Production (2018-2023)

5 Market Analysis by Type
5.1 World Pet Disease Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Parasiticides
5.2.2 Anti-infectives
5.2.3 Anti-inflammatory
5.2.4 Analgesics
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Pet Disease Drugs Production by Type (2018-2029)
5.3.2 World Pet Disease Drugs Production Value by Type (2018-2029)
5.3.3 World Pet Disease Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Pet Disease Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Infectious Diseases
6.2.2 Dermatologic Diseases
6.2.3 Pain
6.2.4 Orthopedic Diseases
6.2.5 Behavioral Diseases
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World Pet Disease Drugs Production by Application (2018-2029)
6.3.2 World Pet Disease Drugs Production Value by Application (2018-2029)
6.3.3 World Pet Disease Drugs Average Price by Application (2018-2029)

7 Company Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Details
7.1.2 Merck & Co., Inc. Major Business
7.1.3 Merck & Co., Inc. Pet Disease Drugs Product and Services
7.1.4 Merck & Co., Inc. Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck & Co., Inc. Recent Developments/Updates
7.1.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.2 Ceva
7.2.1 Ceva Details
7.2.2 Ceva Major Business
7.2.3 Ceva Pet Disease Drugs Product and Services
7.2.4 Ceva Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Ceva Recent Developments/Updates
7.2.6 Ceva Competitive Strengths & Weaknesses
7.3 Vetoquinol S.A.
7.3.1 Vetoquinol S.A. Details
7.3.2 Vetoquinol S.A. Major Business
7.3.3 Vetoquinol S.A. Pet Disease Drugs Product and Services
7.3.4 Vetoquinol S.A. Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Vetoquinol S.A. Recent Developments/Updates
7.3.6 Vetoquinol S.A. Competitive Strengths & Weaknesses
7.4 Zoetis
7.4.1 Zoetis Details
7.4.2 Zoetis Major Business
7.4.3 Zoetis Pet Disease Drugs Product and Services
7.4.4 Zoetis Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Zoetis Recent Developments/Updates
7.4.6 Zoetis Competitive Strengths & Weaknesses
7.5 Virbac
7.5.1 Virbac Details
7.5.2 Virbac Major Business
7.5.3 Virbac Pet Disease Drugs Product and Services
7.5.4 Virbac Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Virbac Recent Developments/Updates
7.5.6 Virbac Competitive Strengths & Weaknesses
7.6 Bimeda
7.6.1 Bimeda Details
7.6.2 Bimeda Major Business
7.6.3 Bimeda Pet Disease Drugs Product and Services
7.6.4 Bimeda Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bimeda Recent Developments/Updates
7.6.6 Bimeda Competitive Strengths & Weaknesses
7.7 Calier
7.7.1 Calier Details
7.7.2 Calier Major Business
7.7.3 Calier Pet Disease Drugs Product and Services
7.7.4 Calier Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Calier Recent Developments/Updates
7.7.6 Calier Competitive Strengths & Weaknesses
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Details
7.8.2 Boehringer Ingelheim Major Business
7.8.3 Boehringer Ingelheim Pet Disease Drugs Product and Services
7.8.4 Boehringer Ingelheim Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Boehringer Ingelheim Recent Developments/Updates
7.8.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.9 Elanco Animal Health
7.9.1 Elanco Animal Health Details
7.9.2 Elanco Animal Health Major Business
7.9.3 Elanco Animal Health Pet Disease Drugs Product and Services
7.9.4 Elanco Animal Health Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Elanco Animal Health Recent Developments/Updates
7.9.6 Elanco Animal Health Competitive Strengths & Weaknesses
7.10 Dechra Pharmaceuticals
7.10.1 Dechra Pharmaceuticals Details
7.10.2 Dechra Pharmaceuticals Major Business
7.10.3 Dechra Pharmaceuticals Pet Disease Drugs Product and Services
7.10.4 Dechra Pharmaceuticals Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Dechra Pharmaceuticals Recent Developments/Updates
7.10.6 Dechra Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Norbrook Laboratories
7.11.1 Norbrook Laboratories Details
7.11.2 Norbrook Laboratories Major Business
7.11.3 Norbrook Laboratories Pet Disease Drugs Product and Services
7.11.4 Norbrook Laboratories Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Norbrook Laboratories Recent Developments/Updates
7.11.6 Norbrook Laboratories Competitive Strengths & Weaknesses
7.12 Chanelle Pharma
7.12.1 Chanelle Pharma Details
7.12.2 Chanelle Pharma Major Business
7.12.3 Chanelle Pharma Pet Disease Drugs Product and Services
7.12.4 Chanelle Pharma Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Chanelle Pharma Recent Developments/Updates
7.12.6 Chanelle Pharma Competitive Strengths & Weaknesses
7.13 K-Laser USA
7.13.1 K-Laser USA Details
7.13.2 K-Laser USA Major Business
7.13.3 K-Laser USA Pet Disease Drugs Product and Services
7.13.4 K-Laser USA Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 K-Laser USA Recent Developments/Updates
7.13.6 K-Laser USA Competitive Strengths & Weaknesses
7.14 Assisi Animal Health
7.14.1 Assisi Animal Health Details
7.14.2 Assisi Animal Health Major Business
7.14.3 Assisi Animal Health Pet Disease Drugs Product and Services
7.14.4 Assisi Animal Health Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Assisi Animal Health Recent Developments/Updates
7.14.6 Assisi Animal Health Competitive Strengths & Weaknesses
7.15 Multi Radiance Medical
7.15.1 Multi Radiance Medical Details
7.15.2 Multi Radiance Medical Major Business
7.15.3 Multi Radiance Medical Pet Disease Drugs Product and Services
7.15.4 Multi Radiance Medical Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Multi Radiance Medical Recent Developments/Updates
7.15.6 Multi Radiance Medical Competitive Strengths & Weaknesses
7.16 Avazzia
7.16.1 Avazzia Details
7.16.2 Avazzia Major Business
7.16.3 Avazzia Pet Disease Drugs Product and Services
7.16.4 Avazzia Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Avazzia Recent Developments/Updates
7.16.6 Avazzia Competitive Strengths & Weaknesses
7.17 SOUND Technologies
7.17.1 SOUND Technologies Details
7.17.2 SOUND Technologies Major Business
7.17.3 SOUND Technologies Pet Disease Drugs Product and Services
7.17.4 SOUND Technologies Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 SOUND Technologies Recent Developments/Updates
7.17.6 SOUND Technologies Competitive Strengths & Weaknesses
7.18 IRM Enterprises
7.18.1 IRM Enterprises Details
7.18.2 IRM Enterprises Major Business
7.18.3 IRM Enterprises Pet Disease Drugs Product and Services
7.18.4 IRM Enterprises Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 IRM Enterprises Recent Developments/Updates
7.18.6 IRM Enterprises Competitive Strengths & Weaknesses
7.19 Ashish Life Science
7.19.1 Ashish Life Science Details
7.19.2 Ashish Life Science Major Business
7.19.3 Ashish Life Science Pet Disease Drugs Product and Services
7.19.4 Ashish Life Science Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Ashish Life Science Recent Developments/Updates
7.19.6 Ashish Life Science Competitive Strengths & Weaknesses
7.20 Century Pharmaceuticals
7.20.1 Century Pharmaceuticals Details
7.20.2 Century Pharmaceuticals Major Business
7.20.3 Century Pharmaceuticals Pet Disease Drugs Product and Services
7.20.4 Century Pharmaceuticals Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Century Pharmaceuticals Recent Developments/Updates
7.20.6 Century Pharmaceuticals Competitive Strengths & Weaknesses
7.21 VETINDIA Pharmaceuticals
7.21.1 VETINDIA Pharmaceuticals Details
7.21.2 VETINDIA Pharmaceuticals Major Business
7.21.3 VETINDIA Pharmaceuticals Pet Disease Drugs Product and Services
7.21.4 VETINDIA Pharmaceuticals Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 VETINDIA Pharmaceuticals Recent Developments/Updates
7.21.6 VETINDIA Pharmaceuticals Competitive Strengths & Weaknesses
7.22 Ourofino Animal Health
7.22.1 Ourofino Animal Health Details
7.22.2 Ourofino Animal Health Major Business
7.22.3 Ourofino Animal Health Pet Disease Drugs Product and Services
7.22.4 Ourofino Animal Health Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Ourofino Animal Health Recent Developments/Updates
7.22.6 Ourofino Animal Health Competitive Strengths & Weaknesses
7.23 SeQuent Scientific
7.23.1 SeQuent Scientific Details
7.23.2 SeQuent Scientific Major Business
7.23.3 SeQuent Scientific Pet Disease Drugs Product and Services
7.23.4 SeQuent Scientific Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 SeQuent Scientific Recent Developments/Updates
7.23.6 SeQuent Scientific Competitive Strengths & Weaknesses
7.24 LABINDIA Healthcare
7.24.1 LABINDIA Healthcare Details
7.24.2 LABINDIA Healthcare Major Business
7.24.3 LABINDIA Healthcare Pet Disease Drugs Product and Services
7.24.4 LABINDIA Healthcare Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 LABINDIA Healthcare Recent Developments/Updates
7.24.6 LABINDIA Healthcare Competitive Strengths & Weaknesses
7.25 Morvel Laboratories
7.25.1 Morvel Laboratories Details
7.25.2 Morvel Laboratories Major Business
7.25.3 Morvel Laboratories Pet Disease Drugs Product and Services
7.25.4 Morvel Laboratories Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.25.5 Morvel Laboratories Recent Developments/Updates
7.25.6 Morvel Laboratories Competitive Strengths & Weaknesses
7.26 Richter Pharma
7.26.1 Richter Pharma Details
7.26.2 Richter Pharma Major Business
7.26.3 Richter Pharma Pet Disease Drugs Product and Services
7.26.4 Richter Pharma Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.26.5 Richter Pharma Recent Developments/Updates
7.26.6 Richter Pharma Competitive Strengths & Weaknesses
7.27 Zuche Pharmaceuticals
7.27.1 Zuche Pharmaceuticals Details
7.27.2 Zuche Pharmaceuticals Major Business
7.27.3 Zuche Pharmaceuticals Pet Disease Drugs Product and Services
7.27.4 Zuche Pharmaceuticals Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.27.5 Zuche Pharmaceuticals Recent Developments/Updates
7.27.6 Zuche Pharmaceuticals Competitive Strengths & Weaknesses
7.28 Fidelis Animal Health
7.28.1 Fidelis Animal Health Details
7.28.2 Fidelis Animal Health Major Business
7.28.3 Fidelis Animal Health Pet Disease Drugs Product and Services
7.28.4 Fidelis Animal Health Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.28.5 Fidelis Animal Health Recent Developments/Updates
7.28.6 Fidelis Animal Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Pet Disease Drugs Industry Chain
8.2 Pet Disease Drugs Upstream Analysis
8.2.1 Pet Disease Drugs Core Raw Materials
8.2.2 Main Manufacturers of Pet Disease Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pet Disease Drugs Production Mode
8.6 Pet Disease Drugs Procurement Model
8.7 Pet Disease Drugs Industry Sales Model and Sales Channels
8.7.1 Pet Disease Drugs Sales Model
8.7.2 Pet Disease Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Pet Disease Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Pet Disease Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Pet Disease Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Pet Disease Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Pet Disease Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Pet Disease Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Pet Disease Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Pet Disease Drugs Production Market Share by Region (2018-2023)
Table 9. World Pet Disease Drugs Production Market Share by Region (2024-2029)
Table 10. World Pet Disease Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Pet Disease Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Pet Disease Drugs Major Market Trends
Table 13. World Pet Disease Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Pet Disease Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Pet Disease Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Pet Disease Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Pet Disease Drugs Producers in 2022
Table 18. World Pet Disease Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Pet Disease Drugs Producers in 2022
Table 20. World Pet Disease Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Pet Disease Drugs Company Evaluation Quadrant
Table 22. World Pet Disease Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Pet Disease Drugs Production Site of Key Manufacturer
Table 24. Pet Disease Drugs Market: Company Product Type Footprint
Table 25. Pet Disease Drugs Market: Company Product Application Footprint
Table 26. Pet Disease Drugs Competitive Factors
Table 27. Pet Disease Drugs New Entrant and Capacity Expansion Plans
Table 28. Pet Disease Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Pet Disease Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Pet Disease Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Pet Disease Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pet Disease Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Pet Disease Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Pet Disease Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Pet Disease Drugs Production Market Share (2018-2023)
Table 37. China Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pet Disease Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Pet Disease Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Pet Disease Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Pet Disease Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pet Disease Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Pet Disease Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Pet Disease Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Pet Disease Drugs Production Market Share (2018-2023)
Table 47. World Pet Disease Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Pet Disease Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Pet Disease Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Pet Disease Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Pet Disease Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Pet Disease Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Pet Disease Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Pet Disease Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Pet Disease Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Pet Disease Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Pet Disease Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Pet Disease Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Pet Disease Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Pet Disease Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co., Inc. Major Business
Table 63. Merck & Co., Inc. Pet Disease Drugs Product and Services
Table 64. Merck & Co., Inc. Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck & Co., Inc. Recent Developments/Updates
Table 66. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 67. Ceva Basic Information, Manufacturing Base and Competitors
Table 68. Ceva Major Business
Table 69. Ceva Pet Disease Drugs Product and Services
Table 70. Ceva Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Ceva Recent Developments/Updates
Table 72. Ceva Competitive Strengths & Weaknesses
Table 73. Vetoquinol S.A. Basic Information, Manufacturing Base and Competitors
Table 74. Vetoquinol S.A. Major Business
Table 75. Vetoquinol S.A. Pet Disease Drugs Product and Services
Table 76. Vetoquinol S.A. Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Vetoquinol S.A. Recent Developments/Updates
Table 78. Vetoquinol S.A. Competitive Strengths & Weaknesses
Table 79. Zoetis Basic Information, Manufacturing Base and Competitors
Table 80. Zoetis Major Business
Table 81. Zoetis Pet Disease Drugs Product and Services
Table 82. Zoetis Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Zoetis Recent Developments/Updates
Table 84. Zoetis Competitive Strengths & Weaknesses
Table 85. Virbac Basic Information, Manufacturing Base and Competitors
Table 86. Virbac Major Business
Table 87. Virbac Pet Disease Drugs Product and Services
Table 88. Virbac Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Virbac Recent Developments/Updates
Table 90. Virbac Competitive Strengths & Weaknesses
Table 91. Bimeda Basic Information, Manufacturing Base and Competitors
Table 92. Bimeda Major Business
Table 93. Bimeda Pet Disease Drugs Product and Services
Table 94. Bimeda Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bimeda Recent Developments/Updates
Table 96. Bimeda Competitive Strengths & Weaknesses
Table 97. Calier Basic Information, Manufacturing Base and Competitors
Table 98. Calier Major Business
Table 99. Calier Pet Disease Drugs Product and Services
Table 100. Calier Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Calier Recent Developments/Updates
Table 102. Calier Competitive Strengths & Weaknesses
Table 103. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 104. Boehringer Ingelheim Major Business
Table 105. Boehringer Ingelheim Pet Disease Drugs Product and Services
Table 106. Boehringer Ingelheim Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Boehringer Ingelheim Recent Developments/Updates
Table 108. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 109. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 110. Elanco Animal Health Major Business
Table 111. Elanco Animal Health Pet Disease Drugs Product and Services
Table 112. Elanco Animal Health Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Elanco Animal Health Recent Developments/Updates
Table 114. Elanco Animal Health Competitive Strengths & Weaknesses
Table 115. Dechra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Dechra Pharmaceuticals Major Business
Table 117. Dechra Pharmaceuticals Pet Disease Drugs Product and Services
Table 118. Dechra Pharmaceuticals Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Dechra Pharmaceuticals Recent Developments/Updates
Table 120. Dechra Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Norbrook Laboratories Basic Information, Manufacturing Base and Competitors
Table 122. Norbrook Laboratories Major Business
Table 123. Norbrook Laboratories Pet Disease Drugs Product and Services
Table 124. Norbrook Laboratories Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Norbrook Laboratories Recent Developments/Updates
Table 126. Norbrook Laboratories Competitive Strengths & Weaknesses
Table 127. Chanelle Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Chanelle Pharma Major Business
Table 129. Chanelle Pharma Pet Disease Drugs Product and Services
Table 130. Chanelle Pharma Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Chanelle Pharma Recent Developments/Updates
Table 132. Chanelle Pharma Competitive Strengths & Weaknesses
Table 133. K-Laser USA Basic Information, Manufacturing Base and Competitors
Table 134. K-Laser USA Major Business
Table 135. K-Laser USA Pet Disease Drugs Product and Services
Table 136. K-Laser USA Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. K-Laser USA Recent Developments/Updates
Table 138. K-Laser USA Competitive Strengths & Weaknesses
Table 139. Assisi Animal Health Basic Information, Manufacturing Base and Competitors
Table 140. Assisi Animal Health Major Business
Table 141. Assisi Animal Health Pet Disease Drugs Product and Services
Table 142. Assisi Animal Health Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Assisi Animal Health Recent Developments/Updates
Table 144. Assisi Animal Health Competitive Strengths & Weaknesses
Table 145. Multi Radiance Medical Basic Information, Manufacturing Base and Competitors
Table 146. Multi Radiance Medical Major Business
Table 147. Multi Radiance Medical Pet Disease Drugs Product and Services
Table 148. Multi Radiance Medical Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Multi Radiance Medical Recent Developments/Updates
Table 150. Multi Radiance Medical Competitive Strengths & Weaknesses
Table 151. Avazzia Basic Information, Manufacturing Base and Competitors
Table 152. Avazzia Major Business
Table 153. Avazzia Pet Disease Drugs Product and Services
Table 154. Avazzia Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Avazzia Recent Developments/Updates
Table 156. Avazzia Competitive Strengths & Weaknesses
Table 157. SOUND Technologies Basic Information, Manufacturing Base and Competitors
Table 158. SOUND Technologies Major Business
Table 159. SOUND Technologies Pet Disease Drugs Product and Services
Table 160. SOUND Technologies Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. SOUND Technologies Recent Developments/Updates
Table 162. SOUND Technologies Competitive Strengths & Weaknesses
Table 163. IRM Enterprises Basic Information, Manufacturing Base and Competitors
Table 164. IRM Enterprises Major Business
Table 165. IRM Enterprises Pet Disease Drugs Product and Services
Table 166. IRM Enterprises Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. IRM Enterprises Recent Developments/Updates
Table 168. IRM Enterprises Competitive Strengths & Weaknesses
Table 169. Ashish Life Science Basic Information, Manufacturing Base and Competitors
Table 170. Ashish Life Science Major Business
Table 171. Ashish Life Science Pet Disease Drugs Product and Services
Table 172. Ashish Life Science Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Ashish Life Science Recent Developments/Updates
Table 174. Ashish Life Science Competitive Strengths & Weaknesses
Table 175. Century Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 176. Century Pharmaceuticals Major Business
Table 177. Century Pharmaceuticals Pet Disease Drugs Product and Services
Table 178. Century Pharmaceuticals Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Century Pharmaceuticals Recent Developments/Updates
Table 180. Century Pharmaceuticals Competitive Strengths & Weaknesses
Table 181. VETINDIA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 182. VETINDIA Pharmaceuticals Major Business
Table 183. VETINDIA Pharmaceuticals Pet Disease Drugs Product and Services
Table 184. VETINDIA Pharmaceuticals Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. VETINDIA Pharmaceuticals Recent Developments/Updates
Table 186. VETINDIA Pharmaceuticals Competitive Strengths & Weaknesses
Table 187. Ourofino Animal Health Basic Information, Manufacturing Base and Competitors
Table 188. Ourofino Animal Health Major Business
Table 189. Ourofino Animal Health Pet Disease Drugs Product and Services
Table 190. Ourofino Animal Health Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. Ourofino Animal Health Recent Developments/Updates
Table 192. Ourofino Animal Health Competitive Strengths & Weaknesses
Table 193. SeQuent Scientific Basic Information, Manufacturing Base and Competitors
Table 194. SeQuent Scientific Major Business
Table 195. SeQuent Scientific Pet Disease Drugs Product and Services
Table 196. SeQuent Scientific Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. SeQuent Scientific Recent Developments/Updates
Table 198. SeQuent Scientific Competitive Strengths & Weaknesses
Table 199. LABINDIA Healthcare Basic Information, Manufacturing Base and Competitors
Table 200. LABINDIA Healthcare Major Business
Table 201. LABINDIA Healthcare Pet Disease Drugs Product and Services
Table 202. LABINDIA Healthcare Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 203. LABINDIA Healthcare Recent Developments/Updates
Table 204. LABINDIA Healthcare Competitive Strengths & Weaknesses
Table 205. Morvel Laboratories Basic Information, Manufacturing Base and Competitors
Table 206. Morvel Laboratories Major Business
Table 207. Morvel Laboratories Pet Disease Drugs Product and Services
Table 208. Morvel Laboratories Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 209. Morvel Laboratories Recent Developments/Updates
Table 210. Morvel Laboratories Competitive Strengths & Weaknesses
Table 211. Richter Pharma Basic Information, Manufacturing Base and Competitors
Table 212. Richter Pharma Major Business
Table 213. Richter Pharma Pet Disease Drugs Product and Services
Table 214. Richter Pharma Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 215. Richter Pharma Recent Developments/Updates
Table 216. Richter Pharma Competitive Strengths & Weaknesses
Table 217. Zuche Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 218. Zuche Pharmaceuticals Major Business
Table 219. Zuche Pharmaceuticals Pet Disease Drugs Product and Services
Table 220. Zuche Pharmaceuticals Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 221. Zuche Pharmaceuticals Recent Developments/Updates
Table 222. Fidelis Animal Health Basic Information, Manufacturing Base and Competitors
Table 223. Fidelis Animal Health Major Business
Table 224. Fidelis Animal Health Pet Disease Drugs Product and Services
Table 225. Fidelis Animal Health Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 226. Global Key Players of Pet Disease Drugs Upstream (Raw Materials)
Table 227. Pet Disease Drugs Typical Customers
Table 228. Pet Disease Drugs Typical Distributors
List of Figure
Figure 1. Pet Disease Drugs Picture
Figure 2. World Pet Disease Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pet Disease Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Pet Disease Drugs Production (2018-2029) & (K Units)
Figure 5. World Pet Disease Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Pet Disease Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Pet Disease Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Pet Disease Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Pet Disease Drugs Production (2018-2029) & (K Units)
Figure 10. China Pet Disease Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Pet Disease Drugs Production (2018-2029) & (K Units)
Figure 12. Pet Disease Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Pet Disease Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Pet Disease Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pet Disease Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pet Disease Drugs Markets in 2022
Figure 26. United States VS China: Pet Disease Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Pet Disease Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pet Disease Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Pet Disease Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Pet Disease Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Pet Disease Drugs Production Market Share 2022
Figure 32. World Pet Disease Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Pet Disease Drugs Production Value Market Share by Type in 2022
Figure 34. Parasiticides
Figure 35. Anti-infectives
Figure 36. Anti-inflammatory
Figure 37. Analgesics
Figure 38. Others
Figure 39. World Pet Disease Drugs Production Market Share by Type (2018-2029)
Figure 40. World Pet Disease Drugs Production Value Market Share by Type (2018-2029)
Figure 41. World Pet Disease Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Pet Disease Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Pet Disease Drugs Production Value Market Share by Application in 2022
Figure 44. Infectious Diseases
Figure 45. Dermatologic Diseases
Figure 46. Pain
Figure 47. Orthopedic Diseases
Figure 48. Behavioral Diseases
Figure 49. Other
Figure 50. World Pet Disease Drugs Production Market Share by Application (2018-2029)
Figure 51. World Pet Disease Drugs Production Value Market Share by Application (2018-2029)
Figure 52. World Pet Disease Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 53. Pet Disease Drugs Industry Chain
Figure 54. Pet Disease Drugs Procurement Model
Figure 55. Pet Disease Drugs Sales Model
Figure 56. Pet Disease Drugs Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Pet Disease Drugs Supply, Demand and Key Producers, 2023-2029

Global Pet Disease Drugs Supply, Demand and Key Producers, 2023-2029

Page: 131

Published Date: 19 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Pet Disease Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

These drugs are used to quiet anxious pets or help in reducing anxiety associated with various behavioral issues in pets.

This report studies the global Pet Disease Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pet Disease Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pet Disease Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pet Disease Drugs total production and demand, 2018-2029, (K Units)
Global Pet Disease Drugs total production value, 2018-2029, (USD Million)
Global Pet Disease Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pet Disease Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Pet Disease Drugs domestic production, consumption, key domestic manufacturers and share
Global Pet Disease Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Pet Disease Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pet Disease Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Pet Disease Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc., Ceva, Vetoquinol S.A., Zoetis, Virbac, Bimeda, Calier, Boehringer Ingelheim and Elanco Animal Health, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pet Disease Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Pet Disease Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Pet Disease Drugs Market, Segmentation by Type
Parasiticides
Anti-infectives
Anti-inflammatory
Analgesics
Others

Global Pet Disease Drugs Market, Segmentation by Application
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other

Companies Profiled:
Merck & Co., Inc.
Ceva
Vetoquinol S.A.
Zoetis
Virbac
Bimeda
Calier
Boehringer Ingelheim
Elanco Animal Health
Dechra Pharmaceuticals
Norbrook Laboratories
Chanelle Pharma
K-Laser USA
Assisi Animal Health
Multi Radiance Medical
Avazzia
SOUND Technologies
IRM Enterprises
Ashish Life Science
Century Pharmaceuticals
VETINDIA Pharmaceuticals
Ourofino Animal Health
SeQuent Scientific
LABINDIA Healthcare
Morvel Laboratories
Richter Pharma
Zuche Pharmaceuticals
Fidelis Animal Health

Key Questions Answered
1. How big is the global Pet Disease Drugs market?
2. What is the demand of the global Pet Disease Drugs market?
3. What is the year over year growth of the global Pet Disease Drugs market?
4. What is the production and production value of the global Pet Disease Drugs market?
5. Who are the key producers in the global Pet Disease Drugs market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Pet Disease Drugs Introduction
1.2 World Pet Disease Drugs Supply & Forecast
1.2.1 World Pet Disease Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World Pet Disease Drugs Production (2018-2029)
1.2.3 World Pet Disease Drugs Pricing Trends (2018-2029)
1.3 World Pet Disease Drugs Production by Region (Based on Production Site)
1.3.1 World Pet Disease Drugs Production Value by Region (2018-2029)
1.3.2 World Pet Disease Drugs Production by Region (2018-2029)
1.3.3 World Pet Disease Drugs Average Price by Region (2018-2029)
1.3.4 North America Pet Disease Drugs Production (2018-2029)
1.3.5 Europe Pet Disease Drugs Production (2018-2029)
1.3.6 China Pet Disease Drugs Production (2018-2029)
1.3.7 Japan Pet Disease Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pet Disease Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pet Disease Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Pet Disease Drugs Demand (2018-2029)
2.2 World Pet Disease Drugs Consumption by Region
2.2.1 World Pet Disease Drugs Consumption by Region (2018-2023)
2.2.2 World Pet Disease Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Pet Disease Drugs Consumption (2018-2029)
2.4 China Pet Disease Drugs Consumption (2018-2029)
2.5 Europe Pet Disease Drugs Consumption (2018-2029)
2.6 Japan Pet Disease Drugs Consumption (2018-2029)
2.7 South Korea Pet Disease Drugs Consumption (2018-2029)
2.8 ASEAN Pet Disease Drugs Consumption (2018-2029)
2.9 India Pet Disease Drugs Consumption (2018-2029)

3 World Pet Disease Drugs Manufacturers Competitive Analysis
3.1 World Pet Disease Drugs Production Value by Manufacturer (2018-2023)
3.2 World Pet Disease Drugs Production by Manufacturer (2018-2023)
3.3 World Pet Disease Drugs Average Price by Manufacturer (2018-2023)
3.4 Pet Disease Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pet Disease Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pet Disease Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for Pet Disease Drugs in 2022
3.6 Pet Disease Drugs Market: Overall Company Footprint Analysis
3.6.1 Pet Disease Drugs Market: Region Footprint
3.6.2 Pet Disease Drugs Market: Company Product Type Footprint
3.6.3 Pet Disease Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Pet Disease Drugs Production Value Comparison
4.1.1 United States VS China: Pet Disease Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Pet Disease Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Pet Disease Drugs Production Comparison
4.2.1 United States VS China: Pet Disease Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pet Disease Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Pet Disease Drugs Consumption Comparison
4.3.1 United States VS China: Pet Disease Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Pet Disease Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Pet Disease Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pet Disease Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers Pet Disease Drugs Production (2018-2023)
4.5 China Based Pet Disease Drugs Manufacturers and Market Share
4.5.1 China Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pet Disease Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers Pet Disease Drugs Production (2018-2023)
4.6 Rest of World Based Pet Disease Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pet Disease Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Pet Disease Drugs Production (2018-2023)

5 Market Analysis by Type
5.1 World Pet Disease Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Parasiticides
5.2.2 Anti-infectives
5.2.3 Anti-inflammatory
5.2.4 Analgesics
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Pet Disease Drugs Production by Type (2018-2029)
5.3.2 World Pet Disease Drugs Production Value by Type (2018-2029)
5.3.3 World Pet Disease Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Pet Disease Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Infectious Diseases
6.2.2 Dermatologic Diseases
6.2.3 Pain
6.2.4 Orthopedic Diseases
6.2.5 Behavioral Diseases
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World Pet Disease Drugs Production by Application (2018-2029)
6.3.2 World Pet Disease Drugs Production Value by Application (2018-2029)
6.3.3 World Pet Disease Drugs Average Price by Application (2018-2029)

7 Company Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Details
7.1.2 Merck & Co., Inc. Major Business
7.1.3 Merck & Co., Inc. Pet Disease Drugs Product and Services
7.1.4 Merck & Co., Inc. Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck & Co., Inc. Recent Developments/Updates
7.1.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.2 Ceva
7.2.1 Ceva Details
7.2.2 Ceva Major Business
7.2.3 Ceva Pet Disease Drugs Product and Services
7.2.4 Ceva Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Ceva Recent Developments/Updates
7.2.6 Ceva Competitive Strengths & Weaknesses
7.3 Vetoquinol S.A.
7.3.1 Vetoquinol S.A. Details
7.3.2 Vetoquinol S.A. Major Business
7.3.3 Vetoquinol S.A. Pet Disease Drugs Product and Services
7.3.4 Vetoquinol S.A. Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Vetoquinol S.A. Recent Developments/Updates
7.3.6 Vetoquinol S.A. Competitive Strengths & Weaknesses
7.4 Zoetis
7.4.1 Zoetis Details
7.4.2 Zoetis Major Business
7.4.3 Zoetis Pet Disease Drugs Product and Services
7.4.4 Zoetis Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Zoetis Recent Developments/Updates
7.4.6 Zoetis Competitive Strengths & Weaknesses
7.5 Virbac
7.5.1 Virbac Details
7.5.2 Virbac Major Business
7.5.3 Virbac Pet Disease Drugs Product and Services
7.5.4 Virbac Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Virbac Recent Developments/Updates
7.5.6 Virbac Competitive Strengths & Weaknesses
7.6 Bimeda
7.6.1 Bimeda Details
7.6.2 Bimeda Major Business
7.6.3 Bimeda Pet Disease Drugs Product and Services
7.6.4 Bimeda Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bimeda Recent Developments/Updates
7.6.6 Bimeda Competitive Strengths & Weaknesses
7.7 Calier
7.7.1 Calier Details
7.7.2 Calier Major Business
7.7.3 Calier Pet Disease Drugs Product and Services
7.7.4 Calier Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Calier Recent Developments/Updates
7.7.6 Calier Competitive Strengths & Weaknesses
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Details
7.8.2 Boehringer Ingelheim Major Business
7.8.3 Boehringer Ingelheim Pet Disease Drugs Product and Services
7.8.4 Boehringer Ingelheim Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Boehringer Ingelheim Recent Developments/Updates
7.8.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.9 Elanco Animal Health
7.9.1 Elanco Animal Health Details
7.9.2 Elanco Animal Health Major Business
7.9.3 Elanco Animal Health Pet Disease Drugs Product and Services
7.9.4 Elanco Animal Health Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Elanco Animal Health Recent Developments/Updates
7.9.6 Elanco Animal Health Competitive Strengths & Weaknesses
7.10 Dechra Pharmaceuticals
7.10.1 Dechra Pharmaceuticals Details
7.10.2 Dechra Pharmaceuticals Major Business
7.10.3 Dechra Pharmaceuticals Pet Disease Drugs Product and Services
7.10.4 Dechra Pharmaceuticals Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Dechra Pharmaceuticals Recent Developments/Updates
7.10.6 Dechra Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Norbrook Laboratories
7.11.1 Norbrook Laboratories Details
7.11.2 Norbrook Laboratories Major Business
7.11.3 Norbrook Laboratories Pet Disease Drugs Product and Services
7.11.4 Norbrook Laboratories Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Norbrook Laboratories Recent Developments/Updates
7.11.6 Norbrook Laboratories Competitive Strengths & Weaknesses
7.12 Chanelle Pharma
7.12.1 Chanelle Pharma Details
7.12.2 Chanelle Pharma Major Business
7.12.3 Chanelle Pharma Pet Disease Drugs Product and Services
7.12.4 Chanelle Pharma Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Chanelle Pharma Recent Developments/Updates
7.12.6 Chanelle Pharma Competitive Strengths & Weaknesses
7.13 K-Laser USA
7.13.1 K-Laser USA Details
7.13.2 K-Laser USA Major Business
7.13.3 K-Laser USA Pet Disease Drugs Product and Services
7.13.4 K-Laser USA Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 K-Laser USA Recent Developments/Updates
7.13.6 K-Laser USA Competitive Strengths & Weaknesses
7.14 Assisi Animal Health
7.14.1 Assisi Animal Health Details
7.14.2 Assisi Animal Health Major Business
7.14.3 Assisi Animal Health Pet Disease Drugs Product and Services
7.14.4 Assisi Animal Health Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Assisi Animal Health Recent Developments/Updates
7.14.6 Assisi Animal Health Competitive Strengths & Weaknesses
7.15 Multi Radiance Medical
7.15.1 Multi Radiance Medical Details
7.15.2 Multi Radiance Medical Major Business
7.15.3 Multi Radiance Medical Pet Disease Drugs Product and Services
7.15.4 Multi Radiance Medical Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Multi Radiance Medical Recent Developments/Updates
7.15.6 Multi Radiance Medical Competitive Strengths & Weaknesses
7.16 Avazzia
7.16.1 Avazzia Details
7.16.2 Avazzia Major Business
7.16.3 Avazzia Pet Disease Drugs Product and Services
7.16.4 Avazzia Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Avazzia Recent Developments/Updates
7.16.6 Avazzia Competitive Strengths & Weaknesses
7.17 SOUND Technologies
7.17.1 SOUND Technologies Details
7.17.2 SOUND Technologies Major Business
7.17.3 SOUND Technologies Pet Disease Drugs Product and Services
7.17.4 SOUND Technologies Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 SOUND Technologies Recent Developments/Updates
7.17.6 SOUND Technologies Competitive Strengths & Weaknesses
7.18 IRM Enterprises
7.18.1 IRM Enterprises Details
7.18.2 IRM Enterprises Major Business
7.18.3 IRM Enterprises Pet Disease Drugs Product and Services
7.18.4 IRM Enterprises Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 IRM Enterprises Recent Developments/Updates
7.18.6 IRM Enterprises Competitive Strengths & Weaknesses
7.19 Ashish Life Science
7.19.1 Ashish Life Science Details
7.19.2 Ashish Life Science Major Business
7.19.3 Ashish Life Science Pet Disease Drugs Product and Services
7.19.4 Ashish Life Science Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Ashish Life Science Recent Developments/Updates
7.19.6 Ashish Life Science Competitive Strengths & Weaknesses
7.20 Century Pharmaceuticals
7.20.1 Century Pharmaceuticals Details
7.20.2 Century Pharmaceuticals Major Business
7.20.3 Century Pharmaceuticals Pet Disease Drugs Product and Services
7.20.4 Century Pharmaceuticals Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Century Pharmaceuticals Recent Developments/Updates
7.20.6 Century Pharmaceuticals Competitive Strengths & Weaknesses
7.21 VETINDIA Pharmaceuticals
7.21.1 VETINDIA Pharmaceuticals Details
7.21.2 VETINDIA Pharmaceuticals Major Business
7.21.3 VETINDIA Pharmaceuticals Pet Disease Drugs Product and Services
7.21.4 VETINDIA Pharmaceuticals Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 VETINDIA Pharmaceuticals Recent Developments/Updates
7.21.6 VETINDIA Pharmaceuticals Competitive Strengths & Weaknesses
7.22 Ourofino Animal Health
7.22.1 Ourofino Animal Health Details
7.22.2 Ourofino Animal Health Major Business
7.22.3 Ourofino Animal Health Pet Disease Drugs Product and Services
7.22.4 Ourofino Animal Health Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Ourofino Animal Health Recent Developments/Updates
7.22.6 Ourofino Animal Health Competitive Strengths & Weaknesses
7.23 SeQuent Scientific
7.23.1 SeQuent Scientific Details
7.23.2 SeQuent Scientific Major Business
7.23.3 SeQuent Scientific Pet Disease Drugs Product and Services
7.23.4 SeQuent Scientific Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 SeQuent Scientific Recent Developments/Updates
7.23.6 SeQuent Scientific Competitive Strengths & Weaknesses
7.24 LABINDIA Healthcare
7.24.1 LABINDIA Healthcare Details
7.24.2 LABINDIA Healthcare Major Business
7.24.3 LABINDIA Healthcare Pet Disease Drugs Product and Services
7.24.4 LABINDIA Healthcare Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 LABINDIA Healthcare Recent Developments/Updates
7.24.6 LABINDIA Healthcare Competitive Strengths & Weaknesses
7.25 Morvel Laboratories
7.25.1 Morvel Laboratories Details
7.25.2 Morvel Laboratories Major Business
7.25.3 Morvel Laboratories Pet Disease Drugs Product and Services
7.25.4 Morvel Laboratories Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.25.5 Morvel Laboratories Recent Developments/Updates
7.25.6 Morvel Laboratories Competitive Strengths & Weaknesses
7.26 Richter Pharma
7.26.1 Richter Pharma Details
7.26.2 Richter Pharma Major Business
7.26.3 Richter Pharma Pet Disease Drugs Product and Services
7.26.4 Richter Pharma Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.26.5 Richter Pharma Recent Developments/Updates
7.26.6 Richter Pharma Competitive Strengths & Weaknesses
7.27 Zuche Pharmaceuticals
7.27.1 Zuche Pharmaceuticals Details
7.27.2 Zuche Pharmaceuticals Major Business
7.27.3 Zuche Pharmaceuticals Pet Disease Drugs Product and Services
7.27.4 Zuche Pharmaceuticals Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.27.5 Zuche Pharmaceuticals Recent Developments/Updates
7.27.6 Zuche Pharmaceuticals Competitive Strengths & Weaknesses
7.28 Fidelis Animal Health
7.28.1 Fidelis Animal Health Details
7.28.2 Fidelis Animal Health Major Business
7.28.3 Fidelis Animal Health Pet Disease Drugs Product and Services
7.28.4 Fidelis Animal Health Pet Disease Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.28.5 Fidelis Animal Health Recent Developments/Updates
7.28.6 Fidelis Animal Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Pet Disease Drugs Industry Chain
8.2 Pet Disease Drugs Upstream Analysis
8.2.1 Pet Disease Drugs Core Raw Materials
8.2.2 Main Manufacturers of Pet Disease Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pet Disease Drugs Production Mode
8.6 Pet Disease Drugs Procurement Model
8.7 Pet Disease Drugs Industry Sales Model and Sales Channels
8.7.1 Pet Disease Drugs Sales Model
8.7.2 Pet Disease Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Pet Disease Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Pet Disease Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Pet Disease Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Pet Disease Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Pet Disease Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Pet Disease Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Pet Disease Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Pet Disease Drugs Production Market Share by Region (2018-2023)
Table 9. World Pet Disease Drugs Production Market Share by Region (2024-2029)
Table 10. World Pet Disease Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Pet Disease Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Pet Disease Drugs Major Market Trends
Table 13. World Pet Disease Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Pet Disease Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Pet Disease Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Pet Disease Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Pet Disease Drugs Producers in 2022
Table 18. World Pet Disease Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Pet Disease Drugs Producers in 2022
Table 20. World Pet Disease Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Pet Disease Drugs Company Evaluation Quadrant
Table 22. World Pet Disease Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Pet Disease Drugs Production Site of Key Manufacturer
Table 24. Pet Disease Drugs Market: Company Product Type Footprint
Table 25. Pet Disease Drugs Market: Company Product Application Footprint
Table 26. Pet Disease Drugs Competitive Factors
Table 27. Pet Disease Drugs New Entrant and Capacity Expansion Plans
Table 28. Pet Disease Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Pet Disease Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Pet Disease Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Pet Disease Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pet Disease Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Pet Disease Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Pet Disease Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Pet Disease Drugs Production Market Share (2018-2023)
Table 37. China Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pet Disease Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Pet Disease Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Pet Disease Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Pet Disease Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Pet Disease Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pet Disease Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Pet Disease Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Pet Disease Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Pet Disease Drugs Production Market Share (2018-2023)
Table 47. World Pet Disease Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Pet Disease Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Pet Disease Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Pet Disease Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Pet Disease Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Pet Disease Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Pet Disease Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Pet Disease Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Pet Disease Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Pet Disease Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Pet Disease Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Pet Disease Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Pet Disease Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Pet Disease Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co., Inc. Major Business
Table 63. Merck & Co., Inc. Pet Disease Drugs Product and Services
Table 64. Merck & Co., Inc. Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck & Co., Inc. Recent Developments/Updates
Table 66. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 67. Ceva Basic Information, Manufacturing Base and Competitors
Table 68. Ceva Major Business
Table 69. Ceva Pet Disease Drugs Product and Services
Table 70. Ceva Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Ceva Recent Developments/Updates
Table 72. Ceva Competitive Strengths & Weaknesses
Table 73. Vetoquinol S.A. Basic Information, Manufacturing Base and Competitors
Table 74. Vetoquinol S.A. Major Business
Table 75. Vetoquinol S.A. Pet Disease Drugs Product and Services
Table 76. Vetoquinol S.A. Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Vetoquinol S.A. Recent Developments/Updates
Table 78. Vetoquinol S.A. Competitive Strengths & Weaknesses
Table 79. Zoetis Basic Information, Manufacturing Base and Competitors
Table 80. Zoetis Major Business
Table 81. Zoetis Pet Disease Drugs Product and Services
Table 82. Zoetis Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Zoetis Recent Developments/Updates
Table 84. Zoetis Competitive Strengths & Weaknesses
Table 85. Virbac Basic Information, Manufacturing Base and Competitors
Table 86. Virbac Major Business
Table 87. Virbac Pet Disease Drugs Product and Services
Table 88. Virbac Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Virbac Recent Developments/Updates
Table 90. Virbac Competitive Strengths & Weaknesses
Table 91. Bimeda Basic Information, Manufacturing Base and Competitors
Table 92. Bimeda Major Business
Table 93. Bimeda Pet Disease Drugs Product and Services
Table 94. Bimeda Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bimeda Recent Developments/Updates
Table 96. Bimeda Competitive Strengths & Weaknesses
Table 97. Calier Basic Information, Manufacturing Base and Competitors
Table 98. Calier Major Business
Table 99. Calier Pet Disease Drugs Product and Services
Table 100. Calier Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Calier Recent Developments/Updates
Table 102. Calier Competitive Strengths & Weaknesses
Table 103. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 104. Boehringer Ingelheim Major Business
Table 105. Boehringer Ingelheim Pet Disease Drugs Product and Services
Table 106. Boehringer Ingelheim Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Boehringer Ingelheim Recent Developments/Updates
Table 108. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 109. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 110. Elanco Animal Health Major Business
Table 111. Elanco Animal Health Pet Disease Drugs Product and Services
Table 112. Elanco Animal Health Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Elanco Animal Health Recent Developments/Updates
Table 114. Elanco Animal Health Competitive Strengths & Weaknesses
Table 115. Dechra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Dechra Pharmaceuticals Major Business
Table 117. Dechra Pharmaceuticals Pet Disease Drugs Product and Services
Table 118. Dechra Pharmaceuticals Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Dechra Pharmaceuticals Recent Developments/Updates
Table 120. Dechra Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Norbrook Laboratories Basic Information, Manufacturing Base and Competitors
Table 122. Norbrook Laboratories Major Business
Table 123. Norbrook Laboratories Pet Disease Drugs Product and Services
Table 124. Norbrook Laboratories Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Norbrook Laboratories Recent Developments/Updates
Table 126. Norbrook Laboratories Competitive Strengths & Weaknesses
Table 127. Chanelle Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Chanelle Pharma Major Business
Table 129. Chanelle Pharma Pet Disease Drugs Product and Services
Table 130. Chanelle Pharma Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Chanelle Pharma Recent Developments/Updates
Table 132. Chanelle Pharma Competitive Strengths & Weaknesses
Table 133. K-Laser USA Basic Information, Manufacturing Base and Competitors
Table 134. K-Laser USA Major Business
Table 135. K-Laser USA Pet Disease Drugs Product and Services
Table 136. K-Laser USA Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. K-Laser USA Recent Developments/Updates
Table 138. K-Laser USA Competitive Strengths & Weaknesses
Table 139. Assisi Animal Health Basic Information, Manufacturing Base and Competitors
Table 140. Assisi Animal Health Major Business
Table 141. Assisi Animal Health Pet Disease Drugs Product and Services
Table 142. Assisi Animal Health Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Assisi Animal Health Recent Developments/Updates
Table 144. Assisi Animal Health Competitive Strengths & Weaknesses
Table 145. Multi Radiance Medical Basic Information, Manufacturing Base and Competitors
Table 146. Multi Radiance Medical Major Business
Table 147. Multi Radiance Medical Pet Disease Drugs Product and Services
Table 148. Multi Radiance Medical Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Multi Radiance Medical Recent Developments/Updates
Table 150. Multi Radiance Medical Competitive Strengths & Weaknesses
Table 151. Avazzia Basic Information, Manufacturing Base and Competitors
Table 152. Avazzia Major Business
Table 153. Avazzia Pet Disease Drugs Product and Services
Table 154. Avazzia Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Avazzia Recent Developments/Updates
Table 156. Avazzia Competitive Strengths & Weaknesses
Table 157. SOUND Technologies Basic Information, Manufacturing Base and Competitors
Table 158. SOUND Technologies Major Business
Table 159. SOUND Technologies Pet Disease Drugs Product and Services
Table 160. SOUND Technologies Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. SOUND Technologies Recent Developments/Updates
Table 162. SOUND Technologies Competitive Strengths & Weaknesses
Table 163. IRM Enterprises Basic Information, Manufacturing Base and Competitors
Table 164. IRM Enterprises Major Business
Table 165. IRM Enterprises Pet Disease Drugs Product and Services
Table 166. IRM Enterprises Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. IRM Enterprises Recent Developments/Updates
Table 168. IRM Enterprises Competitive Strengths & Weaknesses
Table 169. Ashish Life Science Basic Information, Manufacturing Base and Competitors
Table 170. Ashish Life Science Major Business
Table 171. Ashish Life Science Pet Disease Drugs Product and Services
Table 172. Ashish Life Science Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Ashish Life Science Recent Developments/Updates
Table 174. Ashish Life Science Competitive Strengths & Weaknesses
Table 175. Century Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 176. Century Pharmaceuticals Major Business
Table 177. Century Pharmaceuticals Pet Disease Drugs Product and Services
Table 178. Century Pharmaceuticals Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Century Pharmaceuticals Recent Developments/Updates
Table 180. Century Pharmaceuticals Competitive Strengths & Weaknesses
Table 181. VETINDIA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 182. VETINDIA Pharmaceuticals Major Business
Table 183. VETINDIA Pharmaceuticals Pet Disease Drugs Product and Services
Table 184. VETINDIA Pharmaceuticals Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. VETINDIA Pharmaceuticals Recent Developments/Updates
Table 186. VETINDIA Pharmaceuticals Competitive Strengths & Weaknesses
Table 187. Ourofino Animal Health Basic Information, Manufacturing Base and Competitors
Table 188. Ourofino Animal Health Major Business
Table 189. Ourofino Animal Health Pet Disease Drugs Product and Services
Table 190. Ourofino Animal Health Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. Ourofino Animal Health Recent Developments/Updates
Table 192. Ourofino Animal Health Competitive Strengths & Weaknesses
Table 193. SeQuent Scientific Basic Information, Manufacturing Base and Competitors
Table 194. SeQuent Scientific Major Business
Table 195. SeQuent Scientific Pet Disease Drugs Product and Services
Table 196. SeQuent Scientific Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. SeQuent Scientific Recent Developments/Updates
Table 198. SeQuent Scientific Competitive Strengths & Weaknesses
Table 199. LABINDIA Healthcare Basic Information, Manufacturing Base and Competitors
Table 200. LABINDIA Healthcare Major Business
Table 201. LABINDIA Healthcare Pet Disease Drugs Product and Services
Table 202. LABINDIA Healthcare Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 203. LABINDIA Healthcare Recent Developments/Updates
Table 204. LABINDIA Healthcare Competitive Strengths & Weaknesses
Table 205. Morvel Laboratories Basic Information, Manufacturing Base and Competitors
Table 206. Morvel Laboratories Major Business
Table 207. Morvel Laboratories Pet Disease Drugs Product and Services
Table 208. Morvel Laboratories Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 209. Morvel Laboratories Recent Developments/Updates
Table 210. Morvel Laboratories Competitive Strengths & Weaknesses
Table 211. Richter Pharma Basic Information, Manufacturing Base and Competitors
Table 212. Richter Pharma Major Business
Table 213. Richter Pharma Pet Disease Drugs Product and Services
Table 214. Richter Pharma Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 215. Richter Pharma Recent Developments/Updates
Table 216. Richter Pharma Competitive Strengths & Weaknesses
Table 217. Zuche Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 218. Zuche Pharmaceuticals Major Business
Table 219. Zuche Pharmaceuticals Pet Disease Drugs Product and Services
Table 220. Zuche Pharmaceuticals Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 221. Zuche Pharmaceuticals Recent Developments/Updates
Table 222. Fidelis Animal Health Basic Information, Manufacturing Base and Competitors
Table 223. Fidelis Animal Health Major Business
Table 224. Fidelis Animal Health Pet Disease Drugs Product and Services
Table 225. Fidelis Animal Health Pet Disease Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 226. Global Key Players of Pet Disease Drugs Upstream (Raw Materials)
Table 227. Pet Disease Drugs Typical Customers
Table 228. Pet Disease Drugs Typical Distributors
List of Figure
Figure 1. Pet Disease Drugs Picture
Figure 2. World Pet Disease Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pet Disease Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Pet Disease Drugs Production (2018-2029) & (K Units)
Figure 5. World Pet Disease Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Pet Disease Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Pet Disease Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Pet Disease Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Pet Disease Drugs Production (2018-2029) & (K Units)
Figure 10. China Pet Disease Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Pet Disease Drugs Production (2018-2029) & (K Units)
Figure 12. Pet Disease Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Pet Disease Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Pet Disease Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Pet Disease Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pet Disease Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pet Disease Drugs Markets in 2022
Figure 26. United States VS China: Pet Disease Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Pet Disease Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pet Disease Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Pet Disease Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Pet Disease Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Pet Disease Drugs Production Market Share 2022
Figure 32. World Pet Disease Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Pet Disease Drugs Production Value Market Share by Type in 2022
Figure 34. Parasiticides
Figure 35. Anti-infectives
Figure 36. Anti-inflammatory
Figure 37. Analgesics
Figure 38. Others
Figure 39. World Pet Disease Drugs Production Market Share by Type (2018-2029)
Figure 40. World Pet Disease Drugs Production Value Market Share by Type (2018-2029)
Figure 41. World Pet Disease Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Pet Disease Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Pet Disease Drugs Production Value Market Share by Application in 2022
Figure 44. Infectious Diseases
Figure 45. Dermatologic Diseases
Figure 46. Pain
Figure 47. Orthopedic Diseases
Figure 48. Behavioral Diseases
Figure 49. Other
Figure 50. World Pet Disease Drugs Production Market Share by Application (2018-2029)
Figure 51. World Pet Disease Drugs Production Value Market Share by Application (2018-2029)
Figure 52. World Pet Disease Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 53. Pet Disease Drugs Industry Chain
Figure 54. Pet Disease Drugs Procurement Model
Figure 55. Pet Disease Drugs Sales Model
Figure 56. Pet Disease Drugs Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now